Calpastatin ablation aggravates the molecular phenotype in cell and animal models of Huntington disease

Weber, Jonasz Jeremiasz; Kloock, Simon Johannes; Nagel, Maike; Ortiz-Rios, Midea Malena; Hofmann, Julian; Riess, Olaf; Huu Phuc Nguyen

dc.contributor.author	Weber, Jonasz Jeremiasz
dc.contributor.author	Kloock, Simon Johannes
dc.contributor.author	Nagel, Maike
dc.contributor.author	Ortiz-Rios, Midea Malena
dc.contributor.author	Hofmann, Julian
dc.contributor.author	Rieß, Olaf
dc.contributor.author	Nguyen, Huu Phuc
dc.date.accessioned	2019-11-12T09:24:41Z
dc.date.available	2019-11-12T09:24:41Z
dc.date.issued	2018
dc.identifier.issn	1873-7064
dc.identifier.uri	http://hdl.handle.net/10900/94607
dc.language.iso	en	de_DE
dc.publisher	Pergamon - Elsevier Science Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.neuropharm.2018.01.022	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Calpastatin ablation aggravates the molecular phenotype in cell and animal models of Huntington disease	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_02879
utue.publikation.seiten	94-106	de_DE
utue.personen.roh	Weber, Jonasz Jeremiasz
utue.personen.roh	Kloock, Simon Johannes
utue.personen.roh	Nagel, Maike
utue.personen.roh	Ortiz-Rios, Midea Malena
utue.personen.roh	Hofmann, Julian
utue.personen.roh	Riess, Olaf
utue.personen.roh	Huu Phuc Nguyen
dcterms.isPartOf.ZSTitelID	Neuropharmacology	de_DE
dcterms.isPartOf.ZS-Volume	133	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE